OO WGM 202209 - Agenda

OO + CDS + CIMI / CQI

Reps to Patient Empowerment

• ADI-on-FHIR Report Out
• Project 1359 Status
• Project 1541
• ISA Suggestions (time permitting)
• USCDI v4 Proposals (time permitting)
• JIRAs
  • OO Dashboard

OO

• Lab Conceptual Model Reconciliation

OO

• Order Logical Model in FHIR(?)

OO + PC 

FHIR-33394, which deals with Specimen* and Procedure resources (*note JIRA does not show up in OO Specimen dashboard). 

BPM+Health

• Meeting is happening in parallel - 21st to 23
• Initial information orientation - may want to see where this might overlap with our workflow 

OO / II

• Specimen stuff
  • TerminologyCapabilities resource proposal
  • eCC on FHIR update - how to handle specimens (children), SNOMED pre-coordination   ask Alex G for his schedule
  • Example Specimens
    
    • How to handle Grouping Specimens Parent-Child Relations
  • mCode using Procedure resource without specimen relationship https://build.fhir.org/ig/HL7/fhir-mCODE-ig/StructureDefinition-mcode-cancer-related-surgical-procedure.html
• Specimen JIRA
  • Specimen Dashboard
• JIRA Tickets - with II
  • FHIR-37966 - Clarifying groupIdentifier (RE: CommunicationRequest, DeviceRequest (was DeviceUseRequest), MedicationRequest, RequestGroup)

OO / CG

• Glance at ImagingSelection resource (https://build.fhir.org/imagingselection.html)
• Review where we landed with GenomicStudy (and Molseq)
  1. Review pattern for reference options for “subject” in both R5 resources - copied approach on Observation in ballot version.
  2. Multiple subject studies - Group / RelatedPerson instead of Patient for certain use cases - confirm usage is consistent. Bring examples and questions/suggested guidance
     1. https://build.fhir.org/genomicstudy.html#10.4.4.4.1 
• DiagnosticReport update
  1. supportingInfo
  2. Revisit DiagnosticReport + Composition guidance
  3. Do we need an IG? 
• Perhaps add 'valueCodeableReference()' to Obs.value and Obs.component.value
• New release of LRI ? We have some questions about codes (allelic phase / sequence phase relationship)
• TumorMarkers: https://jira.hl7.org/browse/FHIR-28943

OO

JIRAs with whomever is available

At-Home-IVD Test result Reporting Ballot Reconciliation will be taken up after WGM

Gender Harmony IG - Send Reps!

OO / BR&R / DEV

• Device Scope Whitepaper + PSS-2120 "What is a 'Device'?" TR
• Gemini Safe, Effective & Secure Medical Device Interoperability (SES+MDI)
• Resource topics:
  • Device
    • specialization.systemType and specialization.category bindings
    • Mappings - PHD, PoCD
    • Identify stable elements, those that have changed and need further testing 
    • Examples (review/clean-up based on R5)
    • FMM 3 or 4?
  • Device Definition
    • Scope/Boundary 
    • Mappings to EUDAMED, GUDID (Catalog)

OO + PA

• Transport resource
• Updating bodySite element to use BodyStructure resource along with updated codes for BodyStructure 
  • https://build.fhir.org/ig/HL7/fhir-mCODE-ig/StructureDefinition-mcode-cancer-related-surgical-procedure.html
• Specimen JIRA
• v2-FHIR Extensions

OO + CIMI

• Bodystructure FMM 1 to 2?
• No CIMI Topics
• JIRA Progress

OO / DEV